Current location:world >>
The cancer drugs that could improve survival rates if given to patients in the morning
world411People have gathered around
IntroductionGiving cancer patients immunotherapy early in the morning rather than in the afternoon could improve ...
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates.
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs — which help the immune system destroy cancer cells — at the start of the day instead of after lunchtime.
The best results were seen in those treated at about 7.30am. They lived on average another two-and-a-half years.
The researchers who led the trial, published in the European Journal of Cancer, think this may be due to the immune system being more active very early in the day.
Previous studies found there are higher levels of immune cells circulating in the blood in the early morning.
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates, a new study has found (Stock Image)
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths. Pictured: A graphic showing cancer cells
As well as fighting off viruses and bacteria, these can attack cancer cells.
It's thought this is due to the circadian rhythm — our body clock — getting the immune system ready to face any daytime threats from infectious agents, such as in food or transmitted via interacting with people around us.
READ MORE: Alarm over insulin shortage as Brits battling type 1 diabetes fear they'll 'die within days' without access to life-saving drug
AdvertisementImmunotherapy drugs, such as ipilimumab, pembrolizumab and nivolumab, have transformed cancer care in the UK over the past decade or so.
Since 2011 when the first immunotherapy drugs were licensed in the UK for the treatment of malignant melanoma (the most dangerous form of skin cancer), average survival time has risen from six months to five years or more.
Most of these drugs — which can cost up to £100,000 per patient per year — work by attaching to a protein called PD-L1, which is produced in large quantities by cancer cells.
The protein switches off T-cells, defender cells released by the immune system, rendering them unable to attack the cancer.
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths.
The theory is that giving immunotherapy at the start of the day would supercharge this response, as there are more T-cells circulating then.
This follows previous research that showed people given the flu vaccine early in the day produced much higher levels of antibodies than those given the jab later.
Again, the thinking is that the immune system is more active then, so responds much more vigorously to vaccines.
The researchers, from a number of bodies in France — including the PSL Research University in Paris — analysed data from 361 patients with lung or skin cancer that had spread and who were treated with immunotherapy drugs between 2015 and 2021.
Their survival rates were compared with the usual time each patient received treatment — most had roughly the same slot every week or two weeks.
The theory is that giving immunotherapy at the start of the day supercharges a person's immune response, as there are more T-cells then. Picture: Molecular model of an antibody
The results showed those treated before noon survived an average of 30 months; after that average survival was 15.9 months.
Earlier studies also involving the timing of cancer treatments reached similar conclusions.
Now two larger trials are under way in China and the U.S. to see if more lives could be saved just by giving drugs in the morning. The results are expected in the next couple of years.
Dr Pasquale Innominato, a cancer specialist at Ysbyty Gwynedd Hospital in Bangor, Wales, who is also researching the effect of earlier drug delivery, said the findings have the potential to shake-up NHS patient care.
'We need to see results from the bigger trials, but all the evidence so far shows that, whatever type of immunotherapy drug is used and whatever type of cancer it is, there are benefits from giving treatment earlier in the day.'
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Stellar Stories news portal”。http://mauritania.downmusic.org/content-39d599440.html
Related articles
David Cronenberg's new grief
worldDirector David Cronenberg returned to the south of France to premiere his new film The Shrouds, earn ...
【world】
Read moreGerman council approves a revised plan by Tesla to expand its plant near Berlin
worldBERLIN (AP) — A local council in Germany approved a plan by electric carmaker Tesla to expand the gr ...
【world】
Read moreMassive change coming to RHS Chelsea Flower Show
worldThe Chelsea Flower Show has introduced a green medal for sustainability, and will reward gardens wit ...
【world】
Read more
Popular articles
- Kosovo prepares a new draft law on renting prison cells to Denmark after the first proposal failed
- Jonathan Milan sprints to his 3rd stage win in the Giro d'Italia
- The unofficial spokesman for the American muscle car, Tim Kuniskis, is retiring
- The unofficial spokesman for the American muscle car, Tim Kuniskis, is retiring
- Forensic psychiatrist reveals the different types of stalkers
- Protect yourself from ticks with these tips
Latest articles
Ohio judge to rule Monday on whether the state’s abortion ban stands
What to expect in Idaho's state primary and Democratic presidential caucus
Latinos found jobs and cheap housing in a Pennsylvania city but political power has proven elusive
Latinos found jobs and cheap housing in a Pennsylvania city but political power has proven elusive
Dodgers acquire pitcher Yohan Ramírez from Mets for cash
I've fake tanned for 15 years
LINKS
- Tākaka man who died in mysterious circumstances named
- PM Christopher Luxon's tobacco 'talking points' contradicted official advice
- Foodstuffs recalls pre
- Former Governor
- Donald Trump disqualified from Maine ballot in US presidential primary
- Hong Kong news: Hong Kong police block Tiananmen Square candlelit vigil
- Hong Kong news: Hong Kong police block Tiananmen Square candlelit vigil
- Hong Kong protests: ANU student released amid China's approval of national security law
- Changes to road user charges will see EV owners paying more, climate expert says
- Government likened to 'dinosaurs behaving as though it's 1948' over te reo Māori use